Larcher A, Delarue C, Homo-Delarche F, Kikuyama S, Kupryszewski G, Vaudry H
European Institute for Peptide Research, CNRS URA 650, UA INSERM, University of Rouen, Mont-Saint-Aignan, France.
Endocrinology. 1992 Jan;130(1):475-83. doi: 10.1210/endo.130.1.1309345.
In a previous report we demonstrated the presence of a vasotocin (AVT)-like peptide in chromaffin cells of the amphibian adrenal gland and showed that synthetic AVT is a potent stimulator of corticosterone and aldosterone secretion by frog adrenocortical cells. In the present study we evaluated the relative potency of various AVT analogs and investigated the mechanism of action of AVT on frog interrenal (adrenal) tissue. Several AVT agonists, including hydrin 2, oxytocin (OXT), arginine vasopressin (AVP), Lys-conopressin G, and mesotocin (MT), were able to mimic the stimulatory effect of AVT on steroid secretion, but AVT was by far the most potent stimulator of steroidogenesis. In the series of analogs studied, the order of potency was: AVT greater than hydrin 2 greater than OXT greater than AVP greater than Lys-conopressin G greater than MT greater than [deamino-Cys1,D-Arg8]AVP greater than [d(CH2)5,Tyr(OMe)2] AVP. The effect of AVT (5 x 10(-10) M) was totally blocked by both the antidiuretic V2 antagonist [d(CH2)5,D-Phe2,Ile4,Ala9-NH2]AVP (10(-6) M) and the oxytocinergic antagonist [d(CH2)5,Tyr(OMe)2,Orn8]AVT (10(-6) M); the V2 antagonist was approximately twice as potent as the OXT antagonist. In contrast, the V1 antagonist 1-(1-mercapto-4-phenylcyclohexaneacetic acid)-AVP (10(-6) M) did not affect the response of the interrenal tissue to AVT. Indomethacin (5 microM), a cyclooxygenase inhibitor, induced a dramatic decrease in the spontaneous secretion of corticosteroids, but did not impair the stimulatory effect of AVT (5 x 10(-9) M) on corticosterone and aldosterone secretion. In addition, AVT did not stimulate the production of prostaglandin E2, suggesting that prostaglandins are not involved in the mechanism of action of AVT. Concurrently, AVT did not modify cAMP production by frog adrenal slices. In contrast, AVT induced both an increase in inositolphosphate production and a reduction of membrane phospholipid content. We conclude that in the frog adrenal gland, the stimulatory effect of AVT on steroid secretion is mediated through activation of receptors related to the mammalian V2 and/or OXT receptors, which are positively coupled to phosphoinositide-specific phospholipase C.
在之前的一份报告中,我们证明了两栖类肾上腺嗜铬细胞中存在一种类似血管紧张素(AVT)的肽,并表明合成的AVT是青蛙肾上腺皮质细胞分泌皮质酮和醛固酮的有效刺激物。在本研究中,我们评估了各种AVT类似物的相对效力,并研究了AVT对青蛙肾上腺组织的作用机制。几种AVT激动剂,包括hydrin 2、催产素(OXT)、精氨酸加压素(AVP)、赖氨酸锥螺加压素G和中催产素(MT),能够模拟AVT对类固醇分泌的刺激作用,但AVT是迄今为止最有效的类固醇生成刺激物。在所研究的一系列类似物中,效力顺序为:AVT>hydrin 2>OXT>AVP>赖氨酸锥螺加压素G>MT>[脱氨基-Cys1,D-Arg8]AVP>[d(CH2)5,Tyr(OMe)2]AVP。AVT(5×10(-10)M)的作用完全被抗利尿V2拮抗剂[d(CH2)5,D-Phe2,Ile4,Ala9-NH2]AVP(10(-6)M)和催产素能拮抗剂[d(CH2)5,Tyr(OMe)2,Orn8]AVT(10(-6)M)阻断;V2拮抗剂的效力约为OXT拮抗剂的两倍。相比之下,V1拮抗剂1-(1-巯基-4-苯基环己烷乙酸)-AVP(10(-6)M)不影响肾上腺组织对AVT的反应。环氧化酶抑制剂吲哚美辛(5 microM)可导致皮质类固醇的自发分泌显著减少,但不损害AVT(5×10(-9)M)对皮质酮和醛固酮分泌的刺激作用。此外,AVT不刺激前列腺素E2的产生,这表明前列腺素不参与AVT的作用机制。同时,AVT不改变青蛙肾上腺切片中cAMP的产生。相反,AVT可导致肌醇磷酸产生增加和膜磷脂含量减少。我们得出结论,在青蛙肾上腺中,AVT对类固醇分泌的刺激作用是通过激活与哺乳动物V2和/或OXT受体相关的受体介导的,这些受体与磷酸肌醇特异性磷脂酶C呈正偶联。